Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Chemical Listing >> H >> (alphaS,1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-2-hydroxy-5-methoxy-alpha-pentyl-1H-benz[f]indene-1-propanol

(alphaS,1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-2-hydroxy-5-methoxy-alpha-pentyl-1H-benz[f]indene-1-propanol
[CAS# 101692-01-7]

List of Suppliers
Foreland Pharma Co., Ltd. China Inquire  
+86 (10) 5631-5231
5631-5237
qi.ji@forelandpharma.com
QQ chat
Chemical manufacturer since 2011
chemBlink standard supplier since 2014
Complete supplier list of (alphaS,1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-2-hydroxy-5-methoxy-alpha-pentyl-1H-benz[f]indene-1-propanol
Identification
Name (alphaS,1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-2-hydroxy-5-methoxy-alpha-pentyl-1H-benz[f]indene-1-propanol
Molecular Structure CAS # 101692-01-7, (alphaS,1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-2-hydroxy-5-methoxy-alpha-pentyl-1H-benz[f]indene-1-propanol
Molecular Formula C22H34O3
Molecular Weight 346.50
CAS Registry Number 101692-01-7
Properties
Solubility Insoluble (5.2E-3 g/L) (25 ºC), Calc.*
Density 1.062±0.06 g/cm3 (20 ºC 760 Torr), Calc.*
Melting point 71-72 ºC**
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2015 ACD/Labs)
** Moriarty, Robert M.; Journal of Organic Chemistry 2004, V69(6), P1890-1902.
Safety Data
SDS Available
Market Analysis Reports
List of Reports Available for (alphaS,1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-2-hydroxy-5-methoxy-alpha-pentyl-1H-benz[f]indene-1-propanol
Related Products
(4aS-cis)-4,4a,5,6,7,8-Hexahydro-8-hydroxy-4a,8-dimethyl-2(3H)-naphthalenone  (3R,3aR,7S,8aS)-3,3a,4,7,8,8a-Hexahydro-6-(2-hydroxyethyl)-3,7-dimethyl-2H-cyclohepta[b]furan-2-one  (3aS,4S,6aR)-Hexahydro-N-(6-hydroxyhexyl)-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide  (3aS,4R,5S,6aR)-(+)-Hexahydro-5-hydroxy-4-(hydroxymethyl)-2H-cyclopenta[b]furan-2-one  Hexahydro-5-hydroxy-4-(hydroxymethyl)-2H-cyclopenta[b]furan-2-one  (5E)-5-[(3aS,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]-2(1H)-pentalenylidene]pentanoic-2,2,3,3-d4 acid  (3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-1-octen-1-yl]-2H-cyclopenta[b]furan-2-one  (+)-(3aR,4R,5r,6aS)-Hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-5-phenyl-1-pentenyl]-2H-cyclopenta[b]furan-2-one  (+)-(3aR,4R,5r,6aS)-Hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-4-(3-trifluoromethyl)phenoxy-1-butenyl]-2H-cyclopenta[b]furan-2-one  (2a,6a,8a,9ab)-Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one  Hexahydro-3-(hydroxymethyl)-1H-1,4-diazepine-1-carboxylic acid 1,1-dimethylethyl ester  Hexahydro-6-(hydroxymethyl)-1H-1,4-diazepine-1-carboxylic acid 1,1-dimethylethyl ester  Hexahydro-5-(hydroxymethyl)-1H-1,4-diazepine-1-carboxylic acid 1,1-dimethylethyl ester  Hexahydro-4-(hydroxymethyl)-1,1-dimethyl-4-phenyl-1H-azepinium bromide  (4R,12aS)-3,4,6,8,12,12a-Hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid  (6aS,7R,13S,14R,16R)-6,6a,7,13,14,16-Hexahydro-16-(hydroxymethyl)-9-methoxy-8-(methoxymethoxy)-4,10,17-trimethyl-5-(2-propen-1-yloxy)-7,13-imino-12H-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocine-14-carbonitrile  (2E,4E)-N-[(2S,5S)-1,2,3,4,5,6-Hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-3-oxo-1,4-benzodiazocin-8-yl]-5-[4-(trifluoromethyl)phenyl]-2,4-pentadienamide  [3aR-(3aalpha,4alpha,5beta,6aalpha)]-Hexahydro-4-(hydroxymethyl)-5-(phenylmethoxy)-2H-cyclopenta[b]furan-2-one  (1R,2R,3S,6S,7S,7aR)-Hexahydro-3-(hydroxymethyl)-1H-pyrrolizine-1,2,6,7-tetrol  Hexahydro-3-(hydroxymethyl)-1H-pyrrolizine-1,2,7-triol